299 related articles for article (PubMed ID: 11054610)
1. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia.
Baracos VE
Nutrition; 2000 Oct; 16(10):1015-8. PubMed ID: 11054610
[TBL] [Abstract][Full Text] [Related]
2. Anabolic and catabolic mediators.
Baracos VE
Curr Opin Clin Nutr Metab Care; 1998 May; 1(3):241-4. PubMed ID: 10565355
[TBL] [Abstract][Full Text] [Related]
3. Cancer cachexia: from experimental models to patient management.
Costelli P; Baccino FM
Curr Opin Clin Nutr Metab Care; 2000 May; 3(3):177-81. PubMed ID: 10871232
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.
Attaix D; Combaret L; Tilignac T; Taillandier D
Mol Biol Rep; 1999 Apr; 26(1-2):77-82. PubMed ID: 10363651
[TBL] [Abstract][Full Text] [Related]
5. Loss of skeletal muscle in cancer: biochemical mechanisms.
Tisdale MJ
Front Biosci; 2001 Feb; 6():D164-74. PubMed ID: 11171557
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia.
Melstrom LG; Melstrom KA; Ding XZ; Adrian TE
Histol Histopathol; 2007 Jul; 22(7):805-14. PubMed ID: 17455154
[TBL] [Abstract][Full Text] [Related]
7. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise.
Al-Majid S; Waters H
Biol Res Nurs; 2008 Jul; 10(1):7-20. PubMed ID: 18705151
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP-ubiquitin-dependent proteolysis.
Costelli P; Baccino FM
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):407-12. PubMed ID: 12806214
[TBL] [Abstract][Full Text] [Related]
9. Cancer anorexia and cachexia.
Tisdale MJ
Nutrition; 2001 May; 17(5):438-42. PubMed ID: 11377146
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the anticatabolic effects of leucine and Ca-β-hydroxy-β-methylbutyrate in experimental models of cancer cachexia.
Mirza KA; Pereira SL; Voss AC; Tisdale MJ
Nutrition; 2014; 30(7-8):807-13. PubMed ID: 24984997
[TBL] [Abstract][Full Text] [Related]
12. [Systemic and local mechanisms leading to cachexia in cancer].
Grabiec K; Burchert M; Milewska M; Błaszczyk M; Grzelkowska-Kowalczyk K
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1397-409. PubMed ID: 24493689
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies.
Martin A; Gallot YS; Freyssenet D
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1150-1167. PubMed ID: 36864755
[TBL] [Abstract][Full Text] [Related]
14. Cancer cachexia: metabolic alterations and clinical manifestations.
Tisdale MJ
Nutrition; 1997 Jan; 13(1):1-7. PubMed ID: 9058439
[TBL] [Abstract][Full Text] [Related]
15. Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies.
Baracos VE
Cancer; 2001 Sep; 92(6 Suppl):1669-77. PubMed ID: 11598885
[TBL] [Abstract][Full Text] [Related]
16. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
[TBL] [Abstract][Full Text] [Related]
17. Catabolism of skeletal muscle proteins and its reversal in cancer cachexia.
Tisdale MJ
Nestle Nutr Workshop Ser Clin Perform Programme; 2000; 4():135-43; discussion 144-6. PubMed ID: 11490570
[No Abstract] [Full Text] [Related]
18. TNF-α and cancer cachexia: Molecular insights and clinical implications.
Patel HJ; Patel BM
Life Sci; 2017 Feb; 170():56-63. PubMed ID: 27919820
[TBL] [Abstract][Full Text] [Related]
19. Waste management - cytokines, growth factors and cachexia.
Saini A; Al-Shanti N; Stewart CE
Cytokine Growth Factor Rev; 2006 Dec; 17(6):475-86. PubMed ID: 17118696
[TBL] [Abstract][Full Text] [Related]
20. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
